High alpha-methylacyl-CoA racemase (AMACR) is associated with ERG expression and with adverse clinical outcome in patients with localized prostate cancer
Crossref DOI link: https://doi.org/10.1007/s13277-016-5075-1
Published Online: 2016-06-07
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Box, Adrian
Alshalalfa, Mohammed
Hegazy, Samar A.
Donnelly, Bryan
Bismar, Tarek A.
Funding for this research was provided by:
Prostate Cancer Canada (B2013-01)
Prostate Cancer Foundation
License valid from 2016-06-07